{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T12:57:03Z","timestamp":1780491423182,"version":"3.54.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T00:00:00Z","timestamp":1612396800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T00:00:00Z","timestamp":1612396800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We evaluated the therapeutic outcome of intravitreal injection (IVI) of ganciclovir with\/without oral valganciclovir for cytomegalovirus (CMV) anterior segment infection. We enrolled 61 patients (61 eyes) with PCR-proven CMV anterior segment infection. IVI of ganciclovir (2\u00a0mg\/0.05\u00a0mL) was given as a loading dose; subsequent use of oral valganciclovir (900\u00a0mg twice daily) was determined according to the severity of anterior chamber inflammation after injection. All eyes had IVI of ganciclovir, and 53 patients received oral valganciclovir as adjunctive therapy with a mean duration of 1.9\u00a0months to achieve disease remission. Repeated diagnostic aqueous taps were performed in 37 eyes with suspected recurrence, and CMV DNA was positive in 24 eyes. This therapeutic strategy afforded a median 50% recurrence-free survival time of 47.0\u2009\u00b1\u20098.12\u00a0months. The patients\u2019 mean best corrected visual acuity, intraocular pressure and corneal endothelial cell counts stabilized or improved. Corneal transplantation before CMV infection diagnosis was identified as an independent risk factor for recurrence (hazard ratio 6.81, 95% confidence interval 1.21\u201338.23, <jats:italic>P<\/jats:italic>\u2009=\u20090.029). In patients with CMV anterior segment infection, the relative short-term therapeutic strategy, IVI of ganciclovir in adjunction with\/without oral valganciclovir, effectively achieved a median recurrence-free survival time of nearly 4\u00a0years.<\/jats:p>","DOI":"10.1038\/s41598-021-82637-y","type":"journal-article","created":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T11:08:10Z","timestamp":1612436890000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Treatment of cytomegalovirus anterior segment infection with intravitreal injection of ganciclovir in adjunction with or without oral valganciclovir: a long-term results"],"prefix":"10.1038","volume":"11","author":[{"given":"Yu-Chun","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene Yu-Chuan","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yih-Shiou","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Hsi","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,4]]},"reference":[{"key":"82637_CR1","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.ophtha.2007.04.053","volume":"115","author":"N Koizumi","year":"2008","unstructured":"Koizumi, N. et al. Cytomegalovirus as an etiologic factor in corneal endotheliitis. Ophthalmology 115, 292-297.e293 (2008).","journal-title":"Ophthalmology"},{"key":"82637_CR2","doi-asserted-by":"crossref","unstructured":"van Boxtel, L. A. A., van der Lelij, A., van der Meer, J. & Los, L. I. Cytomegalovirus as a cause of anterior uveitis in immunocompetent patients. Ophthalmology 114, 1358\u20131362 (2007).","DOI":"10.1016\/j.ophtha.2006.09.035"},{"key":"82637_CR3","doi-asserted-by":"crossref","unstructured":"de Schryver, I. et al. Diagnosis and treatment of cytomegalovirus iridocyclitis without retinal necrosis. Br. J. Ophthalmol. 90, 852\u2013855 (2006).","DOI":"10.1136\/bjo.2005.086546"},{"key":"82637_CR4","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.ajo.2007.12.015","volume":"145","author":"SP Chee","year":"2008","unstructured":"Chee, S. P. et al. Clinical features of cytomegalovirus anterior uveitis in immunocompetent patients. Am. J. Ophthalmol. 145, 834\u2013840. https:\/\/doi.org\/10.1016\/j.ajo.2007.12.015 (2008).","journal-title":"Am. J. Ophthalmol."},{"key":"82637_CR5","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.ajo.2005.09.021","volume":"141","author":"N Koizumi","year":"2006","unstructured":"Koizumi, N. et al. Cytomegalovirus in aqueous humor from an eye with corneal endotheliitis. Am. J. Ophthalmol. 141, 564\u2013565 (2006).","journal-title":"Am. J. Ophthalmol."},{"key":"82637_CR6","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1136\/bjophthalmol-2013-304625","volume":"99","author":"N Koizumi","year":"2015","unstructured":"Koizumi, N. et al. Clinical features and management of cytomegalovirus corneal endotheliitis: Analysis of 106 cases from the Japan corneal endotheliitis study. Br. J. Ophthalmol. 99, 54\u201358. https:\/\/doi.org\/10.1136\/bjophthalmol-2013-304625 (2015).","journal-title":"Br. J. Ophthalmol."},{"key":"82637_CR7","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.ajo.2008.09.001","volume":"146","author":"SP Chee","year":"2008","unstructured":"Chee, S. P. & Jap, A. Presumed fuchs heterochromic iridocyclitis and Posner-Schlossman syndrome: Comparison of cytomegalovirus-positive and negative eyes. Am. J. Ophthalmol. 146, 883\u2013889. https:\/\/doi.org\/10.1016\/j.ajo.2008.09.001 (2008).","journal-title":"Am. J. Ophthalmol."},{"key":"82637_CR8","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1136\/bjo.2009.167767","volume":"94","author":"SP Chee","year":"2010","unstructured":"Chee, S. P. & Jap, A. Cytomegalovirus anterior uveitis: outcome of treatment. Br. J. Ophthalmol. 94, 1648\u20131652. https:\/\/doi.org\/10.1136\/bjo.2009.167767 (2010).","journal-title":"Br. J. Ophthalmol."},{"key":"82637_CR9","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s00417-011-1813-7","volume":"250","author":"SP Chee","year":"2012","unstructured":"Chee, S. P. & Jap, A. Treatment outcome and risk factors for visual loss in Cytomegalovirus endotheliitis. Graefes Arch. Clin. Exp. Ophthalmol. 250, 383\u2013389 (2012).","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"82637_CR10","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.ajo.2014.08.007","volume":"158","author":"CC Su","year":"2014","unstructured":"Su, C. C. et al. Clinical outcomes in cytomegalovirus-positive Posner-Schlossman syndrome patients treated with topical ganciclovir therapy. Am. J. Ophthalmol. 158, 1024-1031.e1022. https:\/\/doi.org\/10.1016\/j.ajo.2014.08.007 (2014).","journal-title":"Am. J. Ophthalmol."},{"key":"82637_CR11","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1111\/j.1442-9071.2012.02888.x","volume":"41","author":"CC Su","year":"2013","unstructured":"Su, C. C. et al. Topical ganciclovir treatment in patients with cytomegalovirus endotheliitis receiving penetrating keratoplasty. Clin. Exp. Ophthalmol. 41, 339\u2013347 (2013).","journal-title":"Clin. Exp. Ophthalmol."},{"key":"82637_CR12","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s00417-009-1195-2","volume":"248","author":"YS Hwang","year":"2010","unstructured":"Hwang, Y. S. et al. Intravitreal loading injection of ganciclovir with or without adjunctive oral valganciclovir for cytomegalovirus anterior uveitis. Graefes Arch. Clin. Exp. Ophthalmol. 248, 263\u2013269. https:\/\/doi.org\/10.1007\/s00417-009-1195-2 (2010).","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"82637_CR13","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12348-016-0078-z","volume":"6","author":"JX Wong","year":"2016","unstructured":"Wong, J. X., Agrawal, R., Wong, E. P. & Teoh, S. C. Efficacy and safety of topical ganciclovir in the management of cytomegalovirus (CMV)-related anterior uveitis. J. Ophthal. Inflamm. Infect. 6, 10. https:\/\/doi.org\/10.1186\/s12348-016-0078-z (2016).","journal-title":"J. Ophthal. Inflamm. Infect."},{"key":"82637_CR14","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1136\/bjophthalmol-2015-307390","volume":"100","author":"AS Chan","year":"2016","unstructured":"Chan, A. S. et al. Histological features of Cytomegalovirus-related corneal graft infections, its associated features and clinical significance. Br. J. Ophthalmol. 100, 601\u2013606. https:\/\/doi.org\/10.1136\/bjophthalmol-2015-307390 (2016).","journal-title":"Br. J. Ophthalmol."},{"key":"82637_CR15","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2018-312196","author":"CH Hsiao","year":"2018","unstructured":"Hsiao, C. H. et al. Prevalence and clinical consequences of cytomegalovirus DNA in the aqueous humour and corneal transplants. Br. J. Ophthalmol. https:\/\/doi.org\/10.1136\/bjophthalmol-2018-312196 (2018).","journal-title":"Br. J. Ophthalmol."},{"key":"82637_CR16","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S1386-6532(02)00042-2","volume":"26","author":"M Stocher","year":"2003","unstructured":"Stocher, M. et al. Parallel detection of five human herpes virus DNAs by a set of real-time polymerase chain reactions in a single run. J. Clin. Virol. 26, 85\u201393 (2003).","journal-title":"J. Clin. Virol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-82637-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-82637-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-82637-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T03:21:47Z","timestamp":1670037707000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-82637-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,4]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["82637"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-82637-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,4]]},"assertion":[{"value":"16 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3105"}}